Evidence map›Paper›PMID 19706827›Full record

ArticleCA: a cancer journal for clinicians

Treating tobacco dependence in a medical setting.

Richard D Hurt, Jon O Ebbert, J Taylor Hays, David D McFadden

Abstract read
In one paragraph

Article in CA: a cancer journal for clinicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. An ethical analysis of endoscopic therapy decision-making in patients with refractory substance use disorder and chronic pancreatitis.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Effect of Tobacco Control Policies on US Smokeless Tobacco Use: A Structured Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Review
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Richard D HurtNicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA. rhurt@mayo.edu
Jon O Ebbert
J Taylor Hays
David D McFadden

Funding

Evaluating Nicoting Lozenges for Treatment of Smokeless Tobacco AddictionR01CA121165 · NCI · MAYO CLINIC ROCHESTER · PI EBBERT, JON O. · 2006 to 2009
$2.0M
Varenicline for Smokeless Tobacco UseR21CA132621 · NCI · MAYO CLINIC ROCHESTER · PI EBBERT, JON O. · 2009 to 2010
$366k
UNSATURATED POLYOLEFINS AND HYDROCARBON CARCINOGENESISR01CA012115 · NCI · OHIO STATE UNIVERSITY · PI PAQUETTE, LEO A · 1985 to 1995
–
NCI NIH HHS R01 CA 12115NCI NIH HHS R01 CA121165NCI NIH HHS R21 CA 132621NCI NIH HHS R21 CA132621
6 · The paper itself

Abstract

The US Public Health Service Guideline for Treating Tobacco Use and Dependence 2008 Update emphasizes tobacco use as a chronic medical disorder; highlights both behavioral counseling and the use of 1 or more of the 7 approved medications; and points out the utility, efficacy, and reach of telephone quitlines. The treatment of users of smokeless tobacco continues to be less than optimal. Although providing evidence-based treatment for tobacco- dependent patients is a challenge for busy physicians, a team approach including trained and certified tobacco treatment specialists (TTS) provides an efficient treatment model. TTS represent a new and growing part of the health care team and hold great potential for expanding the collective tobacco treatment expertise in the medical setting. The effective treatment of tobacco dependence frequently requires tailoring, and often intensifying, interventions (both counseling and pharmacotherapy) to meet the needs of the individual patient.

Indexed as

NicotinePractice Guidelines as TopicAnimalsBenzazepinesBupropionCotinineDopamine Uptake InhibitorsHumansQuinoxalinesReceptors, NicotinicSmoking CessationTobacco Use CessationTobacco Use DisorderTreatment OutcomeUnited StatesUnited States Public Health ServiceBenzazepinesBupropionCotinineDopamine Uptake InhibitorsNicotineQuinoxalinesReceptors, NicotinicVarenicline

Identifiers

PMID19706827
PMCPMC3903579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.